# Immunologic Response to Influenza Vaccination in Children and Adolescents

> **NCT03614975** · PHASE4 · COMPLETED · sponsor: **Richard Zimmerman MD** · enrollment: 166 (actual)

## Conditions studied

- Influenza, Human
- Immune Response

## Interventions

- **BIOLOGICAL:** Flucelvax inactivated influenza vaccine
- **BIOLOGICAL:** Fluzone inactivated influenza vaccine

## Key facts

- **NCT ID:** NCT03614975
- **Lead sponsor:** Richard Zimmerman MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-13
- **Primary completion:** 2018-12-13
- **Final completion:** 2018-12-13
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03614975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03614975, "Immunologic Response to Influenza Vaccination in Children and Adolescents". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03614975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*